Suppr超能文献

1999 年斯德哥尔摩临床化学和检验医学联合会关于实验室医学质量规范的共识会议。

The 1999 Stockholm Consensus Conference on quality specifications in laboratory medicine.

出版信息

Clin Chem Lab Med. 2015 May;53(6):837-40. doi: 10.1515/cclm-2014-0914.

Abstract

The setting of analytical quality specifications in laboratory medicine has been a topic of discussion and debate for over 50 years: 15 years ago, as the subject matured and a profusion of recommendations appeared, many of them from expert groups, it was realised by a number of leading professionals that there was a need for a global consensus on the setting of such specifications. The Stockholm Conference held in 1999 on "Strategies to set global analytical quality specifications in laboratory medicine" achieved this and advocated the ubiquitous application of a hierarchical structure of approaches. The hierarchy has five levels, namely: 1) evaluation of the effect of analytical performance on clinical outcomes in specific clinical settings; 2) evaluation of the effect of analytical performance on clinical decisions in general using a) data based on components of biological variation, or b) analysis of clinicians' opinions; 3) published professional recommendations from a) national and international expert bodies, or b) expert local groups or individuals; 4) performance goals set by a) regulatory bodies, or b) organisers of external quality assessment (EQA) schemes; and 5) goals based on the current state of the art as a) demonstrated by data from EQA or proficiency testing scheme, or b) found in current publications on methodology. This approach has been much used since its wide promulgation, but there have been ongoing criticisms and new developments. The time seems right for an objective reappraisal of recommended strategies to set analytical performance goals.

摘要

在医学检验领域,分析质量规范的设定已经成为一个讨论和争议的话题,已经有超过 50 年的历史:15 年前,随着该主题的成熟和大量建议的出现,其中许多建议来自专家组,一些领先的专业人员意识到,有必要就这类规范的设定达成全球共识。1999 年在斯德哥尔摩举行的“制定全球医学检验分析质量规范策略”会议实现了这一目标,并倡导普遍应用一种方法的分层结构。该层次结构有五个级别,分别是:1)评估分析性能对特定临床环境下临床结果的影响;2)使用 a)基于生物学变异组成部分的数据,或 b)分析临床医生的意见,评估分析性能对一般临床决策的影响;3)来自 a)国家和国际专家机构,或 b)专家当地团体或个人的专业建议;4)由 a)监管机构,或 b)外部质量评估(EQA)计划的组织者设定的性能目标;以及 5)基于 a)来自 EQA 或能力验证计划的数据,或 b)在当前方法学出版物中发现的当前技术状态的目标。自广泛发布以来,这种方法已经被广泛使用,但一直存在持续的批评和新的发展。现在似乎是客观评估设定分析性能目标的推荐策略的合适时机。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验